News

JB Equity appoints New Partner

JB Equity has announced that Glen Illing has joined the private equity firm as Partner. He will take up the position and join the Executive Board from the 1st of August 2015.

Glen Illing joins JB Equity from Topigs Norsvin, one of the most innovative global pig genetics companies. Prior to this he successfully led a management buyout of the SyAqua Group, an Applied Aquaculture Biotechnology company, and spearheaded the group as CEO.

At JB Equity, Glen will focus on investment strategy, deal execution and development of portfolio companies. Importantly he will share his wealth of experience in investments that require bridging the gap between science, technology and business.

Kristian Bennetsen, Managing Partner of JB Equity said; “We are thrilled to have Glen on the JB Equity team. He is a commercially driven leader with an international track record of success in building and developing Life Science, Agribusiness and Biotechnology companies”. Glen Illing commented; “JB Equity’s investment model of combining executives with agricultural expertise, well-positioned companies, and fully developed strategies for value creation is exciting and I am delighted to take part in focusing the firm further along this path”. 

JB Equity appoints New Partner

JB Equity has announced that Glen Illing has joined the private equity firm as Partner. He will take up the position and join the Executive Board from the 1st of August 2015.

Glen Illing joins JB Equity from Topigs Norsvin, one of the most innovative global pig genetics companies. Prior to this he successfully led a management buyout of the SyAqua Group, an Applied Aquaculture Biotechnology company, and spearheaded the group as CEO.

At JB Equity, Glen will focus on investment strategy, deal execution and development of portfolio companies. Importantly he will share his wealth of experience in investments that require bridging the gap between science, technology and business.

Kristian Bennetsen, Managing Partner of JB Equity said; “We are thrilled to have Glen on the JB Equity team. He is a commercially driven leader with an international track record of success in building and developing Life Science, Agribusiness and Biotechnology companies”. Glen Illing commented; “JB Equity’s investment model of combining executives with agricultural expertise, well-positioned companies, and fully developed strategies for value creation is exciting and I am delighted to take part in focusing the firm further along this path”.